CCG
WST icon

Capital CS Group’s West Pharmaceutical WST Stock Holding History

Capital CS Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,893
Closed -$795K – 97
2021
Q3 		$795K Buy
+1,893
New +$798K 0.74% 21
2021
Q2 		– Sell
-3,009
Closed -$848K – 109
2021
Q1 		$848K Buy
+3,009
New +$861K 0.83% 20

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital CS Group's WST Position: Q4 2021 in Review

Capital CS Group sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 1,893 shares — an estimated $795K sold.

Capital CS Group first reported a position in WST in Q1 2021 and held it in 2 quarters. The position peaked at $848K in Q1 2021. 729 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Capital CS Group reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Capital CS Group sold 1,893 West Pharmaceutical shares in Q4 2021, an estimated $795K.
  • Capital CS Group first reported a position in West Pharmaceutical in Q1 2021 and held it in 2 quarters.
  • Capital CS Group's West Pharmaceutical position peaked at $848K in Q1 2021.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Capital CS Group's 13F filing for Q4 2021, filed 20 Jan 2022.